Protalix BioTherapeutics, Inc. (DE) Common Stock (NY:PLX)
2.595
+0.015
(+0.58%)
Streaming Delayed Price
Updated: 11:18 AM EDT, Mar 28, 2025
Add to My Watchlist
All News about Protalix BioTherapeutics, Inc. (DE) Common Stock![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Via Benzinga
Exposures
Product Safety
![]() ![]() ![]() ![]() ![]() Via Benzinga
![]() ![]() ![]() ![]() ![]()
The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping
April 28, 2021
Via Benzinga
Exposures
Product Safety
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|